BACKGROUND & AIMS: Visceral adiposity is associated with hepatic steatosis,
inflammation, and fibrosis in non-alcoholic fatty liver disease (NAFLD). The visceral …

Aliment Pharmacol Ther 2012; 35: 238–247 Summary Background Metabolic factors have
been associated with liver damage in patients with non‐alcoholic fatty liver disease …

(1) Background: In order to avoid a liver biopsy in non-alcoholic fatty liver disease (NAFLD),
several noninvasive biomarkers have been studied lately. Therefore, we aimed to evaluate …

Abstract Background & Aims Although evidence indicates that visceral adipose tissue is
associated with nonalcoholic fatty liver disease (NAFLD), it is unclear whether the visceral …

Background and aims: Visceral adiposity index (VAI), calculated with body mass index, high-
density lipoprotein cholesterol, triglyceride and waist circumference, has been proposed as …

Background: Nonalcoholic fatty liver disease (NAFLD) is associated with obesity, type 2
diabetes mellitus, and dyslipidemia. It is well known that the presence of visceral fat …

Abstract Background and Aim Many abdominal obesity indices such as waist circumference
(WC), lipid accumulation product (LAP), visceral obesity index (VAI), and Chinese VAI …

Nonalcoholic fatty liver disease (NAFLD) is associated with visceral obesity. However, the
association between visceral adipose tissue (VAT) area and fibrosis in NAFLD patients has …

Background To address the hypothesis that liver steatosis causes systemic insulin
resistance, we sought to determine the liver histological feature that most strongly …

Background. There is sparse literature on the association of adipose tissue with liver
histology in patients with nonalcoholic fatty liver disease (NAFLD). Aim. To study the …